Monthly Archives: August 2015

A Major Loss for Consumers: FDA Proposed Rule on Biosimilar Naming Threatens Savings and Offers No Gain in Safety

This morning’s proposed rule on biosimilar naming marks a major win for PhRMA and BIO and a loss for consumers, not to mention a reversal of FDA policy.  At a time when more than 70% of Americans believe drug companies

Tagged with: , , , , , ,
Posted in Biosimilars, Health Care Costs, Pharmaceuticals

True Public Service: A Moment of Appreciation for Frances Oldham Kelsey and Dedicated Countless Others at the FDA

Earlier this month Dr. Frances Oldham Kelsey passed away.  Although not a household name today, she became that rare thing: a civil servant who was not anonymous.  To the contrary, for a time, Dr. Kelsey was recognized by the public

Tagged with: , , , , , ,
Posted in Pharmaceuticals